title: Malignant hyperthermia during sevoflurane administration.
authors.affiliation: Department of Anesthesiology and Critical Care, CHU Pitié-Salpêtrière, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Ducart
authors.forename: P
authors.initials: P
authors.lastname: Adnet
authors.forename: B
authors.initials: B
authors.lastname: Renaud
authors.forename: B
authors.initials: B
authors.lastname: Riou
authors.forename: R
authors.initials: R
authors.lastname: Krivosic-Horber
mesh_terms: D000328:Adult; D000777:Anesthetics / Q000009:adverse effects*; D002110:Caffeine; D004198:Disease Susceptibility / Q000175:diagnosis; D004987:Ethers / Q000009:adverse effects*; D005260:Female; D006221:Halothane; D006801:Humans; D008305:Malignant Hyperthermia / Q000175:diagnosis / Q000209:etiology*; D008738:Methyl Ethers; D000077149:Sevoflurane
chemical_list: D000777:Anesthetics; D004987:Ethers; D008738:Methyl Ethers; D000077149:Sevoflurane; D002110:Caffeine; D006221:Halothane